Modulation of genomic and epigenetic end-points by celecoxib

Celecoxib, a nonsteroidal anti-inflammatory drug that selectively targets cyclooxygenase-2, is a promising cancer chemopreventive agent. However, safety concerns have been raised in clinical trials evaluating its ability to prevent colorectal adenomas. The rationale for the herein reported studies w...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Oncotarget
Huvudupphovsmän: Izzotti, Alberto, La Maestra, Sebastiano, Micale, Rosanna T., Pulliero, Alessandra, Geretto, Marta, Balansky, Roumen, De Flora, Silvio
Materialtyp: Artigo
Språk:Inglês
Publicerad: Impact Journals LLC 2018
Ämnen:
Research Paper
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6154745/
https://ncbi.nlm.nih.gov/pubmed/30263093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26062
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk